← Back to headlines
Sanofi's Lunsekimig Drug Shows Positive Results in Asthma and CRSwNP Trials
Sanofi announced that its drug lunsekimig successfully met primary and key secondary endpoints in its Phase 2 trials for both Asthma and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).
7 Apr, 07:26 — 7 Apr, 07:26
Sources
Showing 1 of 1 sources
Related Stories
Mayon Volcano Continues Lava Fountaining and Effusion
just now
NASA's Artemis II Mission Captures Stunning Lunar Footage During Flyby
20m ago
The Artemis II crew talked to colleagues from the ISS – after the story about the Canadian, everyone burst into laughter
20m ago
Extremely Rare Mushroom Species Discovered in Blagaj, Bosnia and Herzegovina
21m ago